Trial reportIrish journal of medical science2026
A novel upper-extremity-based performance test for sarcopenia: reliability and clinical utility of the elbow performance test.
Trial report in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07065448 (The Reliability of the Elbow Isotonic Contraction Test as an Alternative to the Gait Speed Test in Assessing Sarcopenia Severity), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Reliability of the Elbow Isotonic Contraction Test as an Alternative to the Gait Speed Test in Assessing Sarcopenia Severity
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGiven the limitations of gait speed tests for sarcopenia assessment, this study evaluated the Elbow Performance Test (EPT), a simple upper-extremity alternative.
aimsThis study aimed to evaluate the test-retest reliability of the EPT and its ability to distinguish between older adults with sarcopenia and healthy young controls.
methodsThis cross-sectional study included 96 male participants: 43 older adults with sarcopenia (≥60 years) and 53 healthy young controls (≤40 years). Assessments covered muscle strength, mass, and physical performance, including 4-meter gait speed, the Short Physical Performance Battery (SPPB), and Timed Up and Go (TUG). The EPT required 30 self-paced elbow flexion-extension repetitions with a 1-kg weight. Test-retest reliability was assessed after 7–10 days using intraclass correlation coefficients (ICCs).
resultsAll performance test scores differed significantly between the sarcopenia and control groups (p < 0.01). The EPT showed excellent test–retest reliability in both the control (ICC = 0.932; 95% CI:0.885–0.960) and sarcopenia (ICC = 0.905; 95% CI:0.831–0.947) groups. In terms of reliability, the EPT outperformed gait speed and SPPB in both groups and was comparable to the TUG test in the sarcopenic group.
conclusionsThe EPT demonstrated excellent reliability and effectively distinguished between older adults with sarcopenia and healthy controls. Given its simplicity, high repeatability, and minimal equipment needs, the EPT may serve as a practical tool for assessing upper-extremity muscle performance, particularly in settings where traditional lower-extremity-based tests are less feasible. Further studies are warranted to confirm its broader clinical utility across diverse populations. CLINICAL
trial registrationThis trial was retrospectively registered at ClinicalTrials.gov (Identifier: NCT07065448) on July 03, 2025.
Indexed as
Identifiers
41499000What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.